Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

2.6K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.6K
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a unified approach to hazardous medicinal product management using closed system drug transfer devices.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

Strengthening the hepatitis B care cascade to prevent vertical transmission in Africa: a call to empower midwives.

BMJ global health·2026
Same author

Student-led efforts promoting inclusivity and belonging in US medical schools.

Nature medicine·2026
Same author

Impact of asynchronous online cancer education for nurses on practice outcomes: A systematic review using the kirkpatrick evaluation model.

Nurse education today·2026
Same author

Care professionals' perceptions of the use of PainChek<sup>®</sup> among people living with dementia in Scotland.

BMC geriatrics·2025
Same author

Analysis of the representation of skin tone diversity amongst medical resources illustrating dermatological manifestations of dermatomyositis, systemic sclerosis and vasculitis.

Rheumatology advances in practice·2025

Related Experiment Video

Updated: Jun 3, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.5K

Patient-Reported Outcome Measures in Routine Hematology Cancer Care: A Scoping Review.

Suriya Kirkpatrick1, Karen Campbell, Samantha Harding

  • 1Author Affiliations: North Bristol NHS Trust (Mrs Kirkpatrick, Dr Harding, and Ms Rudd); Edinburgh Napier University (Dr Campbell).

Cancer Nursing
|January 8, 2025
PubMed
Summary
This summary is machine-generated.

Patient-reported outcome measures (PROMs) show promise for hematological cancer care, but their routine implementation is under-researched. More studies are needed to effectively integrate PROMs into clinical practice for better patient outcomes.

Keywords:
Hematology cancerPatient needsPatient-reported outcome measuresTools

More Related Videos

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Related Experiment Videos

Last Updated: Jun 3, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.5K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Area of Science:

  • Hematology
  • Oncology
  • Patient-Reported Outcomes

Background:

  • Hematological cancers significantly impact patients' physical, emotional, and psychosocial well-being.
  • Patient-reported outcome measures (PROMs) are increasingly recognized for their value in oncology.
  • However, the adoption of PROMs in routine hematology care is limited.

Conclusions:

  • While validated PROMs exist, research on their meaningful implementation in routine hematology care is scarce.
  • Limited evidence supports the adoption of PROMs to improve clinical and patient outcomes in hematology.